Search Results - "VAN ROYEN, E. A"

Refine Results
  1. 1

    [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease by WINOGRODZKA, A, BERGMANS, P, BOOIJ, J, VAN ROYEN, E. A, JANSSEN, A. G. M, WOLTERS, E. Ch

    Published in Journal of Neural Transmission (01-01-2001)
    “…We investigated the applicability [123I]FP-CIT SPECT for the assessment of the rate of dopaminergic degeneration in PD. Twenty early-stage PD patients (age…”
    Get full text
    Journal Article
  2. 2

    Drug-naive patients with Parkinson's disease in Hoehn and Yahr stages I and II show a bilateral decrease in striatal dopamine transporters as revealed by [123I]β-CIT SPECT by TISSINGH, G, BERGMANS, P, BOOIJ, J, WINOGRODZKA, A, VAN ROYEN, E. A, STOOF, J. C, WOLTERS, E. C

    Published in Journal of neurology (01-01-1998)
    “…Ten healthy subjects and 16 patients with early Parkinson's disease (PD) were examined with single photon emission computed tomography (SPECT) and…”
    Get full text
    Journal Article
  3. 3

    Octreotide-scintigraphy is a disease-activity parameter in Graves' ophthalmopathy by Gerding, M. N., van der Zant, F. M., van Royen, E. A., Koornneef, L., Krenning, E. P., Wiersinga, W. M., Prummel, M. F.

    Published in Clinical endocrinology (Oxford) (01-03-1999)
    “…OBJECTIVE It is thought that immunosuppressive treatment of Graves' ophthalmopathy should be restricted to patients with active eye disease, but assessing…”
    Get full text
    Journal Article
  4. 4

    Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease by Booij, J, Tissingh, G, Winogrodzka, A, Boer, G J, Stoof, J C, Wolters, E C, van Royen, E A

    Published in European Journal of Nuclear Medicine (01-01-1997)
    “…Loss of striatal dopamine (DA) transporters in Parkinson's disease (PD) has been accurately assessed in vivo by single-photon emission tomography (SPET)…”
    Get full text
    Journal Article
  5. 5

    Higher occupancy of muscarinic receptors by olanzapine than risperidone in patients with schizophrenia A [123I]-IDEX SPECT study by LAVALAYE, J, BOOIJ, J, LINSZEN, D. H, RENEMAN, L, VAN ROYEN, E. A

    Published in Psychopharmacologia (01-06-2001)
    “…In vitro data have shown anticholinergic properties of the atypical antipsychotic drug olanzapine. Substantial occupancy of muscarinic receptors may be an…”
    Get full text
    Journal Article
  6. 6

    [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease by Booij, J, Tissingh, G, Boer, G J, Speelman, J D, Stoof, J C, Janssen, A G, Wolters, E C, van Royen, E A

    “…OBJECTIVES: The main neuropathological feature in Parkinson's disease is a severe degeneration of the dopaminergic neurons in the substantia nigra resulting in…”
    Get full text
    Journal Article
  7. 7

    Effect of age and gender on dopamine transporter imaging with [123I]FP-CIT SPET in healthy volunteers by Lavalaye, J, Booij, J, Reneman, L, Habraken, J B, van Royen, E A

    Published in European journal of nuclear medicine (01-07-2000)
    “…Dopamine transporter imaging is a valuable tool to investigate the integrity of the dopaminergic neurons. To date, several reports have shown an age-associated…”
    Get full text
    Journal Article
  8. 8

    [123I]β-CIT SPECT is a useful method for monitoring dopaminergic degeneration in early stage Parkinson’s disease by Winogrodzka, A, Bergmans, P, Booij, J, van Royen, E A, Stoof, J C, Wolters, E C

    “…Objectives:To examine the validity of [123I]β-CIT SPECT for monitoring the progression of dopaminergic degeneration in Parkinson’s disease; to investigate the…”
    Get full text
    Journal Article
  9. 9

    Unexpected high prevalence of silent pulmonary embolism in patients with deep venous thrombosis by Huisman, M V, Büller, H R, ten Cate, J W, van Royen, E A, Vreeken, J, Kersten, M J, Bakx, B

    Published in Chest (01-03-1989)
    “…In patients presenting with clinically suspected deep vein thrombosis, symptomatic pulmonary embolism is rarely apparent. To assess the prevalence of silent…”
    Get more information
    Journal Article
  10. 10

    Imaging of the dopaminergic neurotransmission system using single-photon emission tomography and positron emission tomography in patients with parkinsonism by Booij, J, Tissingh, G, Winogrodzka, A, van Royen, E A

    Published in European journal of nuclear medicine (01-02-1999)
    “…Parkinsonism is a feature of a number of neurodegenerative diseases, including Parkinson's disease, multiple system atrophy and progressive supranuclear palsy…”
    Get full text
    Journal Article
  11. 11

    Imaging of estrogen receptors in primary and metastatic breast cancer patients with iodine-123-labeled Z-MIVE by Rijks, L J, Bakker, P J, van Tienhoven, G, Noorduyn, L A, Boer, G J, Rietbroek, R C, Taat, C W, Janssen, A G, Veenhof, C H, van Royen, E A

    Published in Journal of clinical oncology (01-07-1997)
    “…To evaluate the feasibility of noninvasive imaging of estrogen receptors (ERs) in primary and metastatic breast cancer with the iodine-123-labeled ER-specific…”
    Get more information
    Journal Article
  12. 12

    Imaging of Dopamine Transporters with Iodine-123-FP-CIT SPECT in Healthy Controls and Patients with Parkinson's Disease by Booij, Jan, Habraken, Jan B.A, Bergmans, Paul, Tissingh, Gerrit, Winogrodzka, Ania, Wolters, Erik Ch, Janssen, Anton G.M, Stoof, Johannes C, van Royen, Eric A

    Published in The Journal of nuclear medicine (1978) (01-11-1998)
    “…Several SPECT studies reported decreased striatal 123I-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iodoph enyl)nortropane ([123I]FP-CIT) binding in…”
    Get full text
    Journal Article
  13. 13

    Determinants of quantitative spectral electroencephalography in early Alzheimer's disease: cognitive function, regional cerebral blood flow, and computed tomography by Claus, J J, Ongerboer De Visser, B W, Bour, L J, Walstra, G J, Hijdra, A, Verbeeten, Jr, B, Van Royen, E A, Kwa, V I, van Gool, W A

    Published in Dementia and geriatric cognitive disorders (01-03-2000)
    “…Electroencephalography (EEG) bands may have different clinical or physiological correlates at initial diagnosis of Alzheimer's disease (AD). We studied 163…”
    Get more information
    Journal Article
  14. 14

    One-Day Protocol for Imaging of the Nigrostriatal Dopaminergic Pathway in Parkinson's Disease by [123I]FPCIT SPECT by Booij, Jan, Hemelaar, Jos T.G.M, Speelman, Johannes D, de Bruin, Kora, Janssen, Anton G.M, van Royen, Eric A

    Published in The Journal of nuclear medicine (1978) (01-05-1999)
    “…Parkinson's disease is characterized by degeneration of dopaminergic neurons, resulting in loss of dopamine transporters in the striatum. Recently, the tracer…”
    Get full text
    Journal Article
  15. 15

    Measurement of temporal regional cerebral perfusion with single-photon emission tomography predicts rate of decline in language function and survival in early Alzheimer's disease by Claus, J J, Walstra, G J, Hijdra, A, Van Royen, E A, Verbeeten, Jr, B, van Gool, W A

    Published in European journal of nuclear medicine (01-03-1999)
    “…We determined the relationship between regional cerebral blood flow (rCBF) measured with single-photon emission tomography (SPET) and decline in cognitive…”
    Get full text
    Journal Article
  16. 16

    Assessment of endogenous dopamine release by methylphenidate challenge using iodine-123 iodobenzamide single-photon emission tomography by Booij, J, Korn, P, Linszen, D H, van Royen, E A

    Published in European Journal of Nuclear Medicine (01-06-1997)
    “…This double-blind, placebo-controlled study assessed pharmacologically induced endogenous dopamine (DA) release in healthy male volunteers (n=12). Changes in…”
    Get full text
    Journal Article
  17. 17

    Quantification and Visualization of Defects of the Functional Dopaminergic System Using an Automatic Algorithm by Habraken, Jan B.A, Booij, Jan, Slomka, Piotr, Sokole, Ellinor Busemann, van Royen, Eric A

    Published in The Journal of nuclear medicine (1978) (01-07-1999)
    “…In SPECT, the binding of radiotracers in brain areas is usually assessed by manual positioning of regions of interest (ROIs). The disadvantages of this method…”
    Get full text
    Journal Article
  18. 18

    Increased myocardial [123I]-metaiodobenzylguanidine uptake after enalapril treatment in patients with chronic heart failure by Somsen, G. A., van Vlies, B., de Milliano, P. A., Borm, J. J., van Royen, E. A., Endert, E., Lie, K. I.

    Published in Heart (British Cardiac Society) (01-09-1996)
    “…OBJECTIVE: To assess non-invasively the effect of enalapril on cardiac sympathetic neuronal uptake function in patients with congestive heart failure, by using…”
    Get full text
    Journal Article
  19. 19

    Human biodistribution and dosimetry of [123I]FP-CIT: a potent radioligand for imaging of dopamine transporters by Booij, J, Busemann Sokole, E, Stabin, M G, Janssen, A G, de Bruin, K, van Royen, E A

    Published in European journal of nuclear medicine (01-01-1998)
    “…This study reports on the biodistribution and radiation dosimetry of iodine-123-labelled N-omega-(flu-…”
    Get full text
    Journal Article
  20. 20

    [123I]beta-CIT single-photon emission tomography in Parkinson's disease reveals a smaller decline in dopamine transporters with age than in controls by Tissingh, G, Bergmans, P, Booij, J, Winogrodzka, A, Stoof, J C, Wolters, E C, Van Royen, E A

    Published in European Journal of Nuclear Medicine (01-09-1997)
    “…In vivo studies using single-photon emission tomography (SPET) and positron emission tomography have shown an age-related decline in the number of striatal…”
    Get full text
    Journal Article